ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease.

Maria I Fonseca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.